Patients with Chronic Lymphocytic Leukemia (CLL) are better off with a combination of ibrutinib and venetoclax. This is more effective than the standard treatment, researchers of Amsterdam UMC discovered.
ICUdata is an ambitious data-sharing project. Intensivist Paul Elbers, one of the initiators, is enthusiastic about the project that is entering its next phase – and it’s going far beyond its initial scope.
The first patients to visit Amsterdam UMC's "post-covid-19 outpatient clinic" in 2020 taught doctors and pharmacists an important lesson: in times of a crisis, information about medication can easily be jeopardized. "This is a valuable lesson for the crises that are doubtless still to come."
Patients with hereditary angioedema often experience sudden swelling in their body that can be extremely painful, disabling and sometimes even fatal. A new drug can prevent these attacks and greatly improve their quality of life, according to an international study coordinated by Amsterdam UMC.
Predicting, delaying and curing hereditary brain diseases; development of drugs against atrial fibrillation without the use of animal testing and the neurobiological assessment of young delinquents: these ambitious plans of three consortia led by Amsterdam UMC have been awarded a total of 11.2 million euros by the Dutch Research Council NWO.
Amsterdam UMC is a global pioneer in the area of 3D printing with living tissue. This means our researchers have to invent almost everything themselves.
